ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-2745

A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that, if exploited, could allow an authenticated attacker (with privileges to create/upda

Published Jun 12, 2025 · catalog updated Jun 12, 2025 · AVEVA PI Web API

Check if you run it

No confirmed exploitation is on record for CVE-2025-2745. EPSS is 0.25%. Act only if a listed version of AVEVA PI Web API is installed.

Gaps on this record

  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium4.5
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.25%
Remediation
Advisory link
Affected products
vendor AVEVA PI Web API 0 ≤2023 SP1

A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that, if exploited, could allow an authenticated attacker (with privileges to create/update annotations or upload media files) to persist arbitrary JavaScript code that will be executed by users who were socially engineered to disable content security policy protections while rendering annotation attachments from within a web browser.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor AVEVA PI Web API 0 ≤2023 SP10 ≤2023 SP1

How to fix CVE-2025-2745

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-2745. EPSS is 0.25%. Act only if a listed version of AVEVA PI Web API is installed.

Which versions are affected?

Compare what you have installed with AVEVA PI Web API 0 ≤2023 SP1 0 ≤2023 SP1. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.25%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Jun 12, 2025 · EUVD

    Detected

    A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that, if exploited, could allow an authenticated attacker (with privileges to create/update annotations or upload media files) to persist arbitrary JavaScript code that will be executed by users who were socially engineered to disable content security policy protections while rendering annotation attachments

  2. Jun 12, 2025 · EUVD

    Updated

    A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that, if exploited, could allow an authenticated attacker (with privileges to create/update annotations or upload media files) to persist arbitrary JavaScript code that will be executed by users who were socially engineered to disable content security policy protections while rendering annotation attachments

Sources

  • CVE.orgVulnerability recordCVE-2025-2745

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-2745

    30-day exploitation probability 0.2%

    first.org
  • EUVDVulnerability recordEUVD-2025-18212

    A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that, if exploited, could allow an authenticated attacker (with privileges to create/update annotations or upload media files) to persist arbitrary JavaScript code that will be executed by

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.